Clinical Trial Update: Clinical Evaluation of Metal Panel Allergens: Mercury, Aluminum and Palladium Dose Response Study [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating dose response of metal panel allergens (mercury, aluminum, palladium) for contact dermatitis; completed with results posted.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Contact Dermatitis

Drugs mentioned

• Aluminum (aluminum)
• Mercury (mercury)
• Palladium (palladium)

Snippet

Sponsor: Allerderm | Conditions: Contact Dermatitis | Phase 2 | Status: COMPLETED | Results posted: 2020-08-24